在患有急性冠状动脉综合征的患者中预测五年结果的预测因素
Luca Di Vito1, Giancarla Scalone1, Federico Di Giusto1
1Cardiology Unit, C. and G. Mazzoni Hospital, 63100 AST Ascoli Piceno, Italy.
Journal of cardiovascular development and disease
|June 25, 2025
概括
非ST段升高的心肌梗塞 (NSTEMI),糖尿病 (DM) 和肌素升高预测急性冠状动脉综合征 (ACS) 后的主要不良心血管事件 (MACE). 这些因素影响动脉样硬化程度和患者在五年内的结果.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 血管生物学 血管生物学
背景情况:
- 急性冠状动脉综合征 (ACS) 后的残留风险会影响患者的预后.
- 调查女性性别,非ST段升高心肌梗塞 (NSTEMI),糖尿病 (DM) 和慢性病 (CKD) 等因素对于了解冠状动脉样硬化程度,罪祸首狭窄位置和生物幽默数据至关重要.
- 评估主要不良心血管事件 (MACE) 和非致命的复发性冠状动脉事件 (RCE) 可以进一步了解患者的治疗结果.
研究的目的:
- 评估NSTEMI,DM,CKD和性别对ACS患者冠状动脉样硬化和生物幽默标志物的影响.
- 为了确定这些因素对MACE和RCE在5年随访期间的预测值.
主要方法:
- 1404名ACS患者被录取并随访长达5年.
- 冠状动脉血管学用于分析罪祸首和非罪祸首的狭窄症.
- 生物幽默数据是在入院时收集的,在出院1个月后和12个月后,根据性别,NSTEMI,DM和CKD状态进行了比较.
主要成果:
- 与STEMI患者相比,NSTEMI患者的总体和非罪缩的数量更高,非罪缩的百分比更高.
- 患有DM的患者有更多的分叉病变,而CKD患者则显示左主疾病的患病率更高.
- 女性患者在出院1个月和12个月后的LDL胆固醇水平升高. NSTEMI,DM和肌水平独立地预测了MACE,NSTEMI患者面临非致命RCE的风险增加.
结论:
- 在ACS后的前五年内,NSTEMI,DM和入院肌水平是MACE的独立预测因素.
- 这些发现突出了关键的风险因素,需要对ACS幸存者进行密切监测和管理.
更多相关视频
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
3.7K
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
224
相关概念视频
01:30Acute Coronary Syndrome III: Diagnostic Studies
26
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
01:28Acute Coronary Syndrome IV: Interprofessional Care
32
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
01:30Acute Coronary Syndrome I: Introduction
81
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
81
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
52
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
52
01:26Acute Coronary Syndrome V: Nursing Management
46
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
46
01:27Coronary Artery Disease V: Interprofessional Care
39
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
39